Philippe L Bedard

58PUBLICATIONS
428CO-AUTHORS
Predictive and prognostic markersMicro- and nanosystemsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Aug 13, 2026
Immune checkpoint blockade sensitivity is linked to endogenous retroelement transcriptional changes in cancer.

|Jun 10, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.

|Jun 04, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.

|Mar 09, 2026
Evaluation of ensilication technology for ambient DNA preservation.

Michael Blas, Celeste Yu, Farnoosh Abbas Aghababazadeh

|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

|Jan 03, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial.

April A N Rose, Jennifer Maxwell, Emmanuelle Rousselle

Pageof 10

Frequent Collaborators

13 joint publications

Lillian L Siu

10 joint publications

Aaron R Hansen

7 joint publications

Trevor J Pugh

7 joint publications

Anna Spreafico